Marshall Wace North America’s Usana Health Sciences USNA Stock Holding History

Marshall Wace North America’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15,554	Closed	-$1.3M	–	1632
2019 Q1	$1.3M	Buy	+15,554	New	+$1.62M	0.01%	620
2018 Q4	–	Sell	-17,284	Closed	-$2.08M	–	1645
2018 Q3	$2.08M	Sell	17,284 -7,716	-31%	-$958K	0.01%	479
2018 Q2	$2.88M	Buy	25,000 +12,422	+99%	+$1.36M	0.02%	670
2018 Q1	$1.08M	Buy	+12,578	New	+$974K	0.01%	977
2017 Q2	–	Sell	-24,756	Closed	-$1.44M	–	1473
2017 Q1	$1.44M	Buy	+24,756	New	+$1.48M	0.01%	640

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Marshall Wace North America's USNA Position: Q2 2019 in Review

Marshall Wace North America sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 15,554 shares — an estimated $1.3M sold.

Marshall Wace North America first reported a position in USNA in Q1 2017 and held it in 5 quarters. The position peaked at $2.88M in Q2 2018. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

Marshall Wace North America reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
Marshall Wace North America sold 15,554 Usana Health Sciences shares in Q2 2019, an estimated $1.3M.
Marshall Wace North America first reported a position in Usana Health Sciences in Q1 2017 and held it in 5 quarters.
Marshall Wace North America's Usana Health Sciences position peaked at $2.88M in Q2 2018.
173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.